Thursday, March 17, 2022 2:17:00 PM
What do you see?
I see a stock in limbo awaiting Q1 movement towards a clinical trial. Any clinical trial! A clinical trial hasn't been started at Algernon going on 2 years now. All we do is fuckin wait around as the paint dries at Algernon's new HQ location.
I expect the offering will be around $4 per share if they can get it. The same playbook as XORTX.
I also expect the share price will experience what Moreau calls "A Softening" of the share price after the offering
Meaning, 1 $ share price is not out of the realm of possibility. I'm thinking we will see 2 $ again no matter what happens.
Thanks Shell.
Is there anybody else out there?
M$
I see a stock in limbo awaiting Q1 movement towards a clinical trial. Any clinical trial! A clinical trial hasn't been started at Algernon going on 2 years now. All we do is fuckin wait around as the paint dries at Algernon's new HQ location.
I expect the offering will be around $4 per share if they can get it. The same playbook as XORTX.
I also expect the share price will experience what Moreau calls "A Softening" of the share price after the offering
Meaning, 1 $ share price is not out of the realm of possibility. I'm thinking we will see 2 $ again no matter what happens.
Thanks Shell.
Is there anybody else out there?
M$
Recent AGNPF News
- Grey Matters Announces Private Placement • GlobeNewswire Inc. • 04/22/2026 11:00:00 AM
- Algernon Health Announces Effective Date of Previously Announced Name Change to “Grey Matters Health Inc.” and its 10:1 Share Consolidation • GlobeNewswire Inc. • 04/15/2026 08:01:00 PM
- Algernon Health Announces Proposed Name Change to “Grey Matters Health Inc.” and a 10:1 Share Consolidation • GlobeNewswire Inc. • 03/31/2026 11:09:55 PM
- Algernon Health Announces NOVASCAN NEUROIMAGING CLINICS™ as the New Brand Name for its U.S. Brain PET Scanning Centers • GlobeNewswire Inc. • 03/25/2026 11:00:00 AM
- Algernon to Open the First Brain Dedicated PET Scanning Clinic in the U.S. at the HCA Florida University Medical Office Building • GlobeNewswire Inc. • 03/23/2026 11:00:00 AM
- Algernon Announces Additional Increase to Private Placement Financing to $858,000 and Final Closing of the Financing • GlobeNewswire Inc. • 12/31/2025 09:01:00 PM
- Algernon Announces Increase to Private Placement Financing to $750,000 and Close of Third Tranche • GlobeNewswire Inc. • 12/23/2025 09:01:00 PM
- Form D/A - Notice of Exempt Offering of Securities: [Amend] • Edgar (US Regulatory) • 12/09/2025 05:01:20 PM
- Algernon Closes Second Tranche of Private Placement Financing • GlobeNewswire Inc. • 11/29/2025 12:51:39 AM
- Algernon Health and American Molecular Imaging Announce Strategic Business and USD $500K Investment Agreement • GlobeNewswire Inc. • 11/17/2025 12:00:00 PM
- Algernon Closes First Tranche of its Recently Announced Private Placement Financing • GlobeNewswire Inc. • 11/15/2025 12:55:26 AM
- Algernon Health Announces Private Placement • GlobeNewswire Inc. • 11/06/2025 12:04:28 PM
- Algernon Pharmaceuticals Completes Name Change to Algernon Health • GlobeNewswire Inc. • 10/15/2025 11:00:00 AM
- Algernon Announces CAD $4 Million Non-Dilutive Financing to Open Four Brain-Specific PET Scan Clinics in the U.S. for Early Stage Alzheimer’s Detection • GlobeNewswire Inc. • 09/25/2025 11:00:00 AM
- Algernon Announces Preferred Share Class Approved at Annual and Special Meeting • GlobeNewswire Inc. • 09/19/2025 08:39:57 PM
